n.kaufmann
TL2 Moderator · Split
Contributes reviews on supplier material. Based in Split.
Joined 13 January 2025 · last posted 15h
79 posts, newest first. Showing up to 150.
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #10 · Compounds › Secretagogues & GH axis · 27 Jul 2026 · 0 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
GLP-1 receptor distribution: central and peripheral Replied, post #97 · Pharmacology › Receptor biology · 24 Jul 2026 · 6 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #45 · Analytics › Method validation · 18 Jul 2026 · 16 likes I read post #43 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
An 18-month record including the parts that went badly Replied, post #71 · Outcomes › Progress reports · 16 Jul 2026 · 2 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Private prescribing in the UK: what is actually involved Replied, post #66 · Regional › UK & Ireland · 16 Jul 2026 · 9 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #46 · Practice › Administration · 14 Jul 2026 · 0 likes This follows post #43 rather than contradicting it. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one…
-
Follow-up: Reading an interaction checker output critically Replied, post #36 · Practice › Interactions · 8 Jul 2026 · 7 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Spreadsheets: an appreciation — what changed since Replied, post #93 · Lounge › Off topic · 7 Jul 2026 · 33 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #39 · Documentation › Doc review · 5 Jul 2026 · 20 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Reading a home test result without over-claiming Replied, post #93 · Analytics › Home & field testing · 25 Jun 2026 · 17 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Second pass at: The storage lookup and where its data comes from Replied, post #34 · Data & Tools › Calculators · 21 Jun 2026 · 0 likes post #33 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…
-
Batch numbers that do not match the vial label — what changed since Replied, post #38 · Sourcing › Red flags · 15 Jun 2026 · 11 likes post #37 is right about the mechanism and I think understates the practical bit. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #109 · Practice › Reconstitution · 15 Jun 2026 · 14 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Micronutrient adequacy at low total intake Replied, post #64 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 6 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #40 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 17 likes Picking up post #37: that is the part I would want checked first. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete…
-
Prescription portability between countries Replied, post #51 · Access › International · 2 Jun 2026 · 27 likes This follows post #48 rather than contradicting it. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #51 · Practice › Reconstitution · 19 May 2026 · 3 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Reading a trial's population section before its results Replied, post #23 · Evidence › Trials · 15 May 2026 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Tracking intake honestly when appetite is absent Replied, post #12 · Nutrition & Training › Protein & intake · 30 Apr 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #67 · Start Here › Welcome · 17 Apr 2026 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
List price versus negotiated price versus what you pay Replied, post #93 · Access › Pricing · 16 Apr 2026 · 15 likes Coming back to post #91, because the follow-up matters more than the original answer. Compute cost per delivered dose at your dose if you want a number you can act on.…
-
List price versus negotiated price versus what you pay Replied, post #78 · Access › Pricing · 14 Apr 2026 · 32 likes post #77 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #2 · Analytics › Mass spectrometry · 10 Apr 2026 · 31 likes This follows the opening post rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Does a peptide degrade silently, with no visual change? Replied, post #4 · Practice › Storage & stability · 1 Apr 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #25 · Evidence › Trials · 29 Mar 2026 · 6 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #4 · marked as the solution · Compounds › Retatrutide · 29 Mar 2026 · 22 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #117 · Access › Pricing · 16 Mar 2026 · 9 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #4 · Practice › Storage & stability · 13 Mar 2026 · 1 like Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 23 Feb 2026 · 5 likes post #21 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #20 · Practice › Administration · 15 Feb 2026 · 14 likes post #19 is right about the mechanism and I think understates the practical bit. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #29 · Research Methods › N-of-1 designs · 7 Feb 2026 · 0 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #45 · Practice › Storage & stability · 30 Jan 2026 · 4 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Aggregates and why a purity assay may miss them entirely Replied, post #57 · Analytics › Impurities & related substances · 7 Jan 2026 · 0 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #48 · Sourcing › Vendor reports · 21 Dec 2025 · 22 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Personal import allowances, compared Replied, post #3 · Access › International · 18 Dec 2025 · 11 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
The decimal-point error, and the habit that catches it Replied, post #97 · Practice › Reconstitution · 17 Dec 2025 · 28 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #9 · Practice › Reconstitution · 16 Dec 2025 · 1 like Coming back to post #7, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #108 · Compounds › Other compounds · 26 Nov 2025 · 21 likes post #107 answers the question as asked. The question underneath it is different. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #50 · Compounds › Other compounds · 24 Nov 2025 · 27 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #22 · Analytics › Method validation · 28 Oct 2025 · 18 likes Worth separating two things that post #18 runs together. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
New subcategory: rationale and scope Replied, post #134 · Meta › Announcements · 27 Oct 2025 · 6 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #110 · Start Here › Welcome · 22 Oct 2025 · 11 likes I read post #108 twice before replying, because I had assumed the opposite. On the reading order question specifically: start with the how-to-ask materials in this…
-
Payment mechanics and the recovery options that do not exist Replied, post #68 · Sourcing › Payments · 22 Oct 2025 · 0 likes This follows post #65 rather than contradicting it. No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #28 · Clinical › Special populations · 28 Sep 2025 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Persistent vomiting and the threshold for seeking help Replied, post #38 · Safety › Adverse events · 22 Sep 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #15 · Evidence › Journal club · 5 Sep 2025 · 2 likes Picking up post #12: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #9 · Data & Tools › Calculators · 2 Sep 2025 · 31 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Tracking that stops updating and then resumes Replied, post #22 · Sourcing › Logistics · 30 Aug 2025 · 4 likes Worth separating two things that post #18 runs together. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling…
-
Insurance and replacement policies, compared — the long version Replied, post #7 · Sourcing › Logistics · 19 Aug 2025 · 5 likes On post #3 — agreed on the reasoning, with one qualification. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…
-
Asking about a compound your prescriber has not heard of Replied, post #130 · Clinical › Prescriber conversations · 18 Aug 2025 · 3 likes Coming back to post #128, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #49 · Practice › Dosing & titration · 13 Aug 2025 · 24 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #95 · Compounds › Semaglutide · 31 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How to research a compound with no human data without deceiving yourself Replied, post #23 · Compounds › Other compounds · 31 Jul 2025 · 10 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #65 · Compounds › Repair & healing peptides · 11 Jul 2025 · 4 likes On post #61 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #45 · Sourcing › Regulatory · 9 Jul 2025 · 22 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #10 · Pharmacology › Receptor biology · 26 Jun 2025 · 14 likes This follows post #7 rather than contradicting it. Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 3 likes post #69 is right about the mechanism and I think understates the practical bit. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
[2026 update] An appeal that failed, and what I would do differently Started this topic · Access › Insurance & coverage · 5 Jun 2025 · 14 likes Posting this under the heading it deserves: An appeal that failed, and what I would do differently Everything below is what sits behind that. Documenting an access…
-
System suitability injections: if they failed, the run did not happen Replied, post #5 · Analytics › HPLC & UHPLC · 4 Jun 2025 · 8 likes post #4 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Pre-registering a personal experiment, seriously Replied, post #44 · Research Methods › N-of-1 designs · 29 May 2025 · 0 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Coming back to: Getting a referral rather than a refusal Replied, post #8 · marked as the solution · Clinical › Prescriber conversations · 27 May 2025 · 33 likes Coming back to post #6, because the follow-up matters more than the original answer. How to ask for what you need: rather than "should I take this", frame it as "I…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #3 · marked as the solution · Analytics › Method validation · 24 May 2025 · 11 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Adjudicated events and why the definition matters — the long version Replied, post #132 · Evidence › Trials · 3 May 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #56 · Evidence › Journal club · 19 Apr 2025 · 4 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #15 · Compounds › Oral incretins · 7 Apr 2025 · 18 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #7 · Evidence › Trials · 30 Mar 2025 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
A supplier that answers analytical questions with restated claims Replied, post #47 · Sourcing › Red flags · 28 Mar 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Telehealth prescribing models in the US Replied, post #74 · Regional › North America · 22 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #163 · Sourcing › Regulatory · 6 Mar 2025 · 0 likes This follows post #160 rather than contradicting it. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #26 · Analytics › COA interpretation · 25 Feb 2025 · 5 likes On post #22 — agreed on the reasoning, with one qualification. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #34 · Documentation › Doc review · 24 Feb 2025 · 0 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Fixed versus detachable needles: the trade-offs Replied, post #114 · Devices › Syringes & needles · 15 Jan 2025 · 16 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #46 · Sourcing › Regulatory · 18 Dec 2024 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Revisiting: Moderation log format change Replied, post #69 · Meta › Announcements · 15 Dec 2024 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #50 · Clinical › Prescriber conversations · 11 Nov 2024 · 19 likes On post #46 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #72 · Clinical › Bloodwork · 1 Oct 2024 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #24 · Analytics › Method validation · 30 Aug 2024 · 19 likes This follows post #21 rather than contradicting it. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #7 · Clinical › Special populations · 29 Aug 2024 · 2 likes Coming back to post #5, because the follow-up matters more than the original answer. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with…
-
Correlation in a self-tracked dataset: what it can support Replied, post #165 · Research Methods › Statistics · 26 Aug 2024 · 29 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.